Target intelligence / Profile preview

CD8 alpha-beta T-cell surface glycoprotein (CD8αβ)

Target
CD8αβ
Molecular classification
Transmembrane glycoprotein, Co-receptor, Immunoglobulin superfamily
01

Overview

The CD8 alpha-beta T-cell surface glycoprotein (CD8αβ) is a transmembrane heterodimeric co-receptor expressed primarily on cytotoxic CD8+ αβ T cells, consisting of CD8α and CD8β chains each with an extracellular IgV-like domain, flexible hinge, transmembrane domain, and cytoplasmic tail. It binds the α3 domain of MHC class I molecules to enhance T-cell receptor (TCR) affinity during antigen recognition, recruits Lck kinase via a zinc-stabilized interaction in the CD8α cytoplasmic tail to initiate TCR signaling through CD3 ITAM phosphorylation, localizes to lipid rafts for immunological synapse formation, and supports T-cell development including thymocyte selection and maturation into memory subsets. CD8αβ acts as a stronger co-stimulator than CD8αα homodimers due to better Lck recruitment, with structural features like conserved Ig folds, disulfide bonds, O-linked glycosylation in the hinge, and palmitoylation aiding function.

Other names
CD8 co-receptorCD8αβ heterodimerCD8 glycoprotein
02

Mechanism of action

Blockade of CD8/MHC-I interaction, Modulation of T-cell activation, Promotion or abrogation of TCR signaling, Engineering into CAR T-cell hinges and transmembrane domains

03

Biological functions

Antigen recognitionT-cell signalingImmune cell maturationThymocyte selectionRecruitment of Lck kinaseLocalization to lipid rafts
04

Disease associations

CancerInfectionAutoimmune disease (via immunomodulation)
05

Safety considerations

Potential overactivation or suppression of T cells leading to activation-induced cell death or impaired immune responseAltered glycosylation affecting MHC-I affinity
06

Interacting drugs

Anti-CD8 monoclonal antibodies (mAbs)

1 more in the full profile.

07

Biomarkers

CD8 expression on T cells (for cytotoxic T lymphocyte identification and monitoring)

Beyond the preview

Go deeper on CD8 alpha-beta T-cell surface glycoprotein (CD8αβ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD8 alpha-beta T-cell surface glycoprotein (CD8αβ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call